Biden's Closed-Door AI Meeting

And this small-cap is at the center of this AI-biotech revolution [logo]( [contact us](mailto:support@secretstradingchoice.com) Dear Fellow Investor, On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... Things are moving so fast, President Biden just met with 8 of the top AI experts in the world to figure out how to regulate it. And [this small-cap]( is at the center of this AI-biotech revolution. On January 9, 2023, Bristol Myers Squibb signed a $2.7 billion deal to have them develop new drugs. On October 6, 2022, Eli Lilly signed a $425 million deal to have their AI-platform develop new drugs. Bill Gates owns 7 million shares of this small company. Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares. [Get the name of the stock here ]( "The Buck Stops Here," [dylan signature] At times, our affiliate partners reach out to the Editors at Secrets Trading Choice with special opportunities for our readers. The message above is one we think you should take a close, serious look at. [logo]( You are receiving this e-mail because you have expressed an interest in the Fіnancial Educatіon nіche on one of our landіng pаges. This email sent to you by Secrets Trading Choice on behalf of Event Horizon LLC. 435 N Dupont Hwy, Dover, DE 19901, United States © 2024 All Rights Reserved. Looking for support? Reach out to us at support@secretstradingchoice.com for assistance. [privacy policy]( [Terms & Conditions]( [Unsubscribe](